Literature DB >> 25309096

Long-term survival after enucleation of a giant esophageal gastrointestinal stromal tumor.

Zhi-Min Mu1, Yuan-Cai Xie1, Xu-Xing Peng1, Hai Zhang1, Gang Hui1, Hao Wu1, Ji-Xian Liu1, Bao-Kun Chen1, Da Wu1, Yi-Wang Ye1.   

Abstract

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms of the gastrointestinal tract. Less than 1% occurs in the esophagus. Surgery is the primary treatment for patients with GISTs. We report a 29-year-old male was admitted after the detection of a posterior mediastinal mass during work-up with routine examination. He did not have any disease-related symptoms. The physical examination was unremarkable. Chest computed tomographic scan, the barium esophagogram and endoscopic esophageal ultrasound showed benign neoplasm. The patient was performed an enucleation surgery through the right posterolateral thoracotomy. The pathology revealed a 13.0 cm × 12.0 cm × 5.0 cm mass. The tumor was CD117 (C-kit), PDGFRA and DOG1 positive. These findings were consistent with a GIST of the esophagus. So the diagnosis of GIST of esophagus was confirmed. The pathological diagnosis of low grade of GIST of esophagus was confirmed. The patient has no evidence of recurrence and is in good clinical conditions up-to date, five years after surgery.

Entities:  

Keywords:  Enucleation; Esophageal gastrointestinal stromal tumor; Follow-up; Long-term survival; Surgery

Mesh:

Substances:

Year:  2014        PMID: 25309096      PMCID: PMC4188917          DOI: 10.3748/wjg.v20.i37.13632

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

Review 1.  Gastrointestinal stromal tumors: pathology and prognosis at different sites.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

Review 2.  Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

Authors:  J-Y Blay; S Bonvalot; P Casali; H Choi; M Debiec-Richter; A P Dei Tos; J-F Emile; A Gronchi; P C W Hogendoorn; H Joensuu; A Le Cesne; J McClure; J Mac Clure; J Maurel; N Nupponen; I Ray-Coquard; P Reichardt; R Sciot; S Stroobants; M van Glabbeke; A van Oosterom; G D Demetri
Journal:  Ann Oncol       Date:  2005-04       Impact factor: 32.976

Review 3.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

Review 4.  Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management.

Authors:  I Pidhorecky; R T Cheney; W G Kraybill; J F Gibbs
Journal:  Ann Surg Oncol       Date:  2000-10       Impact factor: 5.344

5.  Endoscopic enucleation of gastrointestinal stromal tumors of the stomach: report of five cases.

Authors:  Toshio Katoh; Yoshiyuki Itoh; Tomomi Mohri; Hiroshi Suzuki
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

Review 6.  Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients < or = 40 years: an overview based on our case material and the literature.

Authors:  Abbas Agaimy; Peter H Wünsch
Journal:  Langenbecks Arch Surg       Date:  2008-12-23       Impact factor: 3.445

Review 7.  Management of gastrointestinal stromal tumors.

Authors:  Matthew T Hueman; Richard D Schulick
Journal:  Surg Clin North Am       Date:  2008-06       Impact factor: 2.741

8.  Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.

Authors:  Jason S Gold; Mithat Gönen; Antonio Gutiérrez; Javier Martín Broto; Xavier García-del-Muro; Thomas C Smyrk; Robert G Maki; Samuel Singer; Murray F Brennan; Cristina R Antonescu; John H Donohue; Ronald P DeMatteo
Journal:  Lancet Oncol       Date:  2009-09-28       Impact factor: 41.316

9.  Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Authors:  George D Demetri; Peter Reichardt; Yoon-Koo Kang; Jean-Yves Blay; Piotr Rutkowski; Hans Gelderblom; Peter Hohenberger; Michael Leahy; Margaret von Mehren; Heikki Joensuu; Giuseppe Badalamenti; Martin Blackstein; Axel Le Cesne; Patrick Schöffski; Robert G Maki; Sebastian Bauer; Binh Bui Nguyen; Jianming Xu; Toshirou Nishida; John Chung; Christian Kappeler; Iris Kuss; Dirk Laurent; Paolo G Casali
Journal:  Lancet       Date:  2012-11-22       Impact factor: 79.321

10.  Gastrointestinal stromal tumors: A multicenter study of 1160 Turkish cases.

Authors:  Gülen Bülbül Doğusoy
Journal:  Turk J Gastroenterol       Date:  2012-06       Impact factor: 1.852

View more
  7 in total

1.  Effective Downsizing of a Gastroesophageal GIST Using Neoadjuvant Imatinib Mesylate: a Case Report.

Authors:  Syed Asif; Nikhil Gupta; Gurudutt Gupta; Anurag Mehta; Shivendra Singh
Journal:  J Gastrointest Cancer       Date:  2017-06

Review 2.  The imaging features of protruding esophageal lesions.

Authors:  Hayato Tomita; Kunihisa Miyakawa; Shinji Wada; Satoko Okamoto; Tsuyoshi Morimoto; Keiko Kishimoto; Yasuo Nakajima
Journal:  Jpn J Radiol       Date:  2016-03-11       Impact factor: 2.374

3.  Value of 18F-FDG PET/CT for differentiating diagnosis between malignant and benign primary gastric gastrointestinal mesenchymal tumors: a single-center retrospective study.

Authors:  Shengxu Li; Duanyu Lin; Mingdeng Tang; Daojia Liu; Qinghu Lyu; Jieping Zhang
Journal:  J Gastrointest Oncol       Date:  2022-04

4.  A rare case of giant gastrointestinal stromal tumor of the stomach involving the serosal surface.

Authors:  Ali Koyuncuer; Levent Gönlüşen; Ahmet Vecihi Kutsal
Journal:  Int J Surg Case Rep       Date:  2015-05-12

5.  Analysis of giant thoracic neoplasms: Correlations between imaging, pathology and surgical management.

Authors:  Zhen Feng; Meng Li; Fang Liu; Yue Peng; Wangang Ren; Hounai Xie; Zhongmin Peng
Journal:  Thorac Cancer       Date:  2017-06-13       Impact factor: 3.500

6.  Giant gastric stromal tumor mimicking as a posterior mediastinal mass: A case report and literature review.

Authors:  Xiaonan Yin; Chaoyong Shen; Yuan Yin; Zhaolun Cai; Zhixin Chen; Bo Zhang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Clinicopathologic Features and Clinical Outcomes of Esophageal Gastrointestinal Stromal Tumor: Evaluation of a Pooled Case Series.

Authors:  Fan Feng; Yangzi Tian; Zhen Liu; Guanghui Xu; Shushang Liu; Man Guo; Xiao Lian; Daiming Fan; Hongwei Zhang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.